portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 China Jo-Jo Drugstores Q1 net incomeincreases
 
CreateTime:2011-08-19     Source:YellowBrix, Inc. Editor:xujintao
Text Size:       
 

China Jo-Jo Drugstores, Inc.(CJJD.NSDQ), an operator of retail pharmacy chain in China, has reported a net income of $3.24 million, or $0.24 per share, for the first quarter ended June 30, 2011, compared to $2.15 million, or $0.17 per share, for the first quarter ended June 30, 2010.
Net revenues for the first quarter of fiscal 2012 were $21.43 million, compared to $15.21 million for the first quarter of fiscal 2011.

Gross profit for the first quarter of fiscal 2012 was $6.87 million, compared to $4.61 million for the first quarter of fiscal 2011.

Lei Liu, chairman and CEO of the company, said: "We are very pleased to deliver record operating results for the first quarter, which reflect strong sales and increased traffic at both new and existing stores. The substantial increase in sales primarily reflects our ability to accept medical insurance for an increased number of drugs, as well as a broader number of insured individuals under China's government-sponsored insurance programs. All of our stores opened prior to April 1, 2010 are now able to accept government medical insurance. As we continue to apply to accept medical insurance as soon as our stores become eligible to do so, i.e. one year after opening, we anticipate that government-sponsored programs will continue to drive sales as our new stores mature."


Related Reports
China Medical Robot Industry Report, 2020-2026
China Heparin Industry Report, 2015-2018
Global and China Stem Cell Industry Report, 2015-2018
China Medical Robot Industry Report, 2014-2018
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1